Proto Labs (PRLB) Liabilities and Shareholders Equity (2011 - 2026)

Proto Labs' Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $778.6 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 5.58% year-over-year to $778.6 million; the TTM figure through Mar 2026 stood at $3.0 billion (up 1.64% YoY), while the FY2025 annual figure was $763.4 million, up 2.68% from the prior year.
• Liabilities and Shareholders Equity came in at $778.6 million for Q1 2026 at Proto Labs, up from $763.4 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $934.8 million in Q1 2022 to a low of $737.4 million in Q1 2025.
• A 5-year average of $793.7 million and a median of $772.4 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity dropped 15.4% in 2023 and increased 5.58% in 2026, its largest moves.
• Proto Labs' Liabilities and Shareholders Equity stood at $802.2 million in 2022, then decreased by 3.72% to $772.4 million in 2023, then slipped by 3.73% to $743.5 million in 2024, then grew by 2.68% to $763.4 million in 2025, then gained by 1.98% to $778.6 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $778.6 million, $763.4 million, and $756.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison